Shannon Stone

982 total citations
18 papers, 532 citations indexed

About

Shannon Stone is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Shannon Stone has authored 18 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 4 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Shannon Stone's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (8 papers) and Long-Term Effects of COVID-19 (4 papers). Shannon Stone is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (8 papers) and Long-Term Effects of COVID-19 (4 papers). Shannon Stone collaborates with scholars based in United States, Canada and United Kingdom. Shannon Stone's co-authors include Mukesh Kumar, Janhavi P. Natekar, Pratima Kumari, Komal Arora, Hussin A. Rothan, Heather Pathak, Margo A. Brinton, Dawood My, Michael Friend and Deborah Kelly and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Microbiology and Virology.

In The Last Decade

Shannon Stone

18 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shannon Stone United States 9 302 148 67 52 48 18 532
Ji-Hoon Lee South Korea 8 171 0.6× 108 0.7× 31 0.5× 16 0.3× 38 0.8× 18 560
Anton De Spiegeleer Belgium 10 143 0.5× 63 0.4× 132 2.0× 17 0.3× 36 0.8× 26 599
Bruno Revol France 13 165 0.5× 49 0.3× 56 0.8× 19 0.4× 112 2.3× 43 608
Lixue Huang China 12 270 0.9× 426 2.9× 81 1.2× 11 0.2× 65 1.4× 34 725
Jila Masrour-Roudsari Iran 8 121 0.4× 69 0.5× 58 0.9× 26 0.5× 36 0.8× 20 340
Baiba Rozentāle Latvia 10 154 0.5× 72 0.5× 43 0.6× 13 0.3× 83 1.7× 24 398
Davide Masi Italy 11 208 0.7× 45 0.3× 49 0.7× 76 1.5× 61 1.3× 33 489
Maki Konishi Japan 11 138 0.5× 27 0.2× 83 1.2× 28 0.5× 56 1.2× 57 395
Hailong Lin China 16 108 0.4× 71 0.5× 92 1.4× 5 0.1× 65 1.4× 39 613

Countries citing papers authored by Shannon Stone

Since Specialization
Citations

This map shows the geographic impact of Shannon Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Stone more than expected).

Fields of papers citing papers by Shannon Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Stone. The network helps show where Shannon Stone may publish in the future.

Co-authorship network of co-authors of Shannon Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Stone. A scholar is included among the top collaborators of Shannon Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Stone. Shannon Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Jahantigh, Hamid Reza, et al.. (2025). Pathogenicity of SARS-CoV-2 Omicron Subvariants JN.1, KP.2, and EG.5.1 in K18-hACE2 Transgenic Mice. Viruses. 17(9). 1177–1177. 1 indexed citations
3.
Stone, Shannon, Arban Domi, Pratima Kumari, et al.. (2025). Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model. Vaccines. 13(4). 411–411. 1 indexed citations
4.
Stone, Shannon, et al.. (2024). Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice. Frontiers in Microbiology. 15. 1466980–1466980. 6 indexed citations
5.
Oh, Soo Jin, Pratima Kumari, Shannon Stone, et al.. (2024). Upregulation of Neuroinflammation-Associated Genes in the Brain of SARS-CoV-2-Infected Mice. Pathogens. 13(7). 528–528. 7 indexed citations
6.
Dubansky, Benjamin, et al.. (2023). Generation and Characterization of a Multi-Functional Panel of Monoclonal Antibodies for SARS-CoV-2 Research and Treatment. Viruses. 16(1). 64–64. 1 indexed citations
7.
Natekar, Janhavi P., Heather Pathak, Shannon Stone, et al.. (2022). Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice. Viruses. 14(6). 1139–1139. 32 indexed citations
8.
Rothan, Hussin A., Pratima Kumari, Shannon Stone, et al.. (2022). SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways. Pathogens. 11(2). 257–257. 28 indexed citations
9.
Stone, Shannon, Hussin A. Rothan, Janhavi P. Natekar, et al.. (2021). SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice. Viruses. 14(1). 27–27. 24 indexed citations
10.
Kumari, Pratima, Hussin A. Rothan, Janhavi P. Natekar, et al.. (2021). Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses. 13(1). 132–132. 161 indexed citations
11.
Rothan, Hussin A., Shannon Stone, Janhavi P. Natekar, et al.. (2020). The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. Virology. 547. 7–11. 118 indexed citations
12.
Jawara, Musa, David Bell, Thomas R. Burkot, et al.. (2018). New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia. American Journal of Tropical Medicine and Hygiene. 99(6). 1475–1484. 25 indexed citations
13.
Li, Junshan, Michael Friend, Andrew Miller, & Shannon Stone. (2016). A SDD and PCM solution for vaccine storage and outreach. 555–562. 3 indexed citations
14.
15.
Laubscher, Tessa, et al.. (2014). Hypertension in the elderly: new blood pressure targets and prescribing tips.. PubMed. 60(5). 453–6. 2 indexed citations
16.
Tseng, Alice, Michelle Foisy, Christine Hughes, et al.. (2012). Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines. The Canadian Journal of Hospital Pharmacy. 65(2). 125–45. 51 indexed citations
17.
Stone, Shannon, et al.. (2011). Opioids for chronic noncancer pain in the elderly: an osteoarthritis case.. PubMed. 57(8). 907–11. 6 indexed citations
18.
My, Dawood, et al.. (1995). Quality of life during sequential hormone replacement therapy -- a placebo-controlled study.. PubMed. 40(2). 73–8. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji-Hoon Lee Breakdown of academic impact, for papers by Anton De Spiegeleer Breakdown of academic impact, for papers by Bruno Revol Breakdown of academic impact, for papers by Lixue Huang Breakdown of academic impact, for papers by Jila Masrour-Roudsari Breakdown of academic impact, for papers by Baiba Rozentāle Breakdown of academic impact, for papers by Davide Masi Breakdown of academic impact, for papers by Maki Konishi Breakdown of academic impact, for papers by Hailong Lin
Rankless by CCL
2026